Pharma Institute India
- All
- News
- Videos
-
Centre Approves Rs 700 Crore To Set Up Institutes Of Pharma, Medical Technology
The Central government has earmarked Rs 700 crore to set up centres of excellence at the National Institutes of Pharmaceutical, Education & Research (NIPER) over the next five years to boost pharma and medical technology in the country.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Couple Allege Daughter Died After Taking Covishield, To Sue AstraZeneca
The parents of a young woman who died allegedly after being given Covishield are planning to sue the world's largest vaccine maker and the British pharma giant that had developed the vaccine during the Covid pandemic.
-
IIT Kanpur Professor Wins Sun Pharma Science Foundation Research Award
Dr Ateeq is a recipient of the Shanti Swarup Bhatnagar Prize in Medical Sciences (2020). She is also an Elected Fellow of the National Academy of Sciences, India (NASI) and the Indian Academy of Sciences, Bangalore (IASc).
-
Hyderabad Pharma Firm Signs Agreement To Make Covid Drug 2-DG
Hyderabad-based Lee Pharma has entered into an agreement with the Indian Institute of Chemical Technology (IICT), a constituent laboratory of CSIR, to manufacture and commercialise 2-DG used to treat Covid patients, a statement said.
-
AstraZeneca, Novavax Ready To Scale Up COVID-19 Vaccine Production In Tie-Up With Serum Institute
British-Swedish pharma giant AstraZeneca and US pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of COVID-19 vaccines in partnership with the Serum Institute of India.
-
"Please Be Patient": Adar Poonawalla To Nations Waiting For Vaccines
World's biggest vaccine maker Serum Institute of India's Adar Poonawalla this morning urged the nations to "be patient" amid the wait for Covishield, the coronavirus vaccine that the SII has developed in partnership with the Oxford University and British-Swedish pharma firm AstraZeneca.
-
Russian Covid Vaccine Sputnik Could Be Available In India By April: 10 Points
Russian-made Coronavirus vaccine Sputnik -- peer-reviewed by the Lancet Medical Journal -- is undergoing trials in India and could be available for use soon. "I believe the vaccine should be available in India from March- April," Deepak Sapra, the chief of API and pharma services at Dr Reddy's Laboratories, which is manufacturing the vaccine, told...
-
"Hope To Launch Covovax By June 2021": Serum Institute's Adar Poonawalla
Serum Institute of India, the world's biggest vaccine maker, is hopeful of launching Covovax - developed in partnership with American vaccine developer Novavax - by June, its CEO Adar Poonawalla said today. The US-based pharma firm's Covid jab was found to be 89.3 per cent effective in a UK trial.
-
"Happy New Year, All Risks Paid Off": Adar Poonawalla On Vaccine Approval
All the risks taken by Serum Institute have finally paid off, tweeted Adar Poonawalla, the chief executive of the Pune-based vaccine manufacturer, shortly after the country's drug regulator cleared its Covishield vaccine for emergency approval in India.Mr Poonawalla reiteratedthat the Covishieldvaccine -- developed by Serum Institute of India in pa...
-
After Pfizer, Serum Institute Of India Seeks Approval For Covid Vaccine
Serum Institute of India, the world's largest vaccine maker by number of doses produced, has sought government approval for emergency use authorisation of the coronavirus vaccine that it is developing with the University of Oxford and British drugmaker AstraZeneca, sources have said.
-
Applying For Emergency Use Of Covid Vaccine In 2 Weeks: Serum Institute
The Serum Institute will apply within two weeks for an emergency use license of the coronavirus vaccine being developed by the University of Oxford and pharma giant AstraZeneca, the vaccine maker's chief Adar Poonawalla said on Saturday after a meeting with Prime Minister Narendra Modi.
-
PM's 3-City Vaccine Tour Today: Zydus, Bharat Biotech, Serum Institute
Prime Minister Narendra Modi will visit pharma major Zydus Cadila's plant near Ahmedabad on Saturday to get information about the development of its COVID-19 vaccine, Gujarat Deputy Chief Minister Nitin Patel said today.
-
Centre Approves Rs 700 Crore To Set Up Institutes Of Pharma, Medical Technology
The Central government has earmarked Rs 700 crore to set up centres of excellence at the National Institutes of Pharmaceutical, Education & Research (NIPER) over the next five years to boost pharma and medical technology in the country.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Couple Allege Daughter Died After Taking Covishield, To Sue AstraZeneca
The parents of a young woman who died allegedly after being given Covishield are planning to sue the world's largest vaccine maker and the British pharma giant that had developed the vaccine during the Covid pandemic.
-
IIT Kanpur Professor Wins Sun Pharma Science Foundation Research Award
Dr Ateeq is a recipient of the Shanti Swarup Bhatnagar Prize in Medical Sciences (2020). She is also an Elected Fellow of the National Academy of Sciences, India (NASI) and the Indian Academy of Sciences, Bangalore (IASc).
-
Hyderabad Pharma Firm Signs Agreement To Make Covid Drug 2-DG
Hyderabad-based Lee Pharma has entered into an agreement with the Indian Institute of Chemical Technology (IICT), a constituent laboratory of CSIR, to manufacture and commercialise 2-DG used to treat Covid patients, a statement said.
-
AstraZeneca, Novavax Ready To Scale Up COVID-19 Vaccine Production In Tie-Up With Serum Institute
British-Swedish pharma giant AstraZeneca and US pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of COVID-19 vaccines in partnership with the Serum Institute of India.
-
"Please Be Patient": Adar Poonawalla To Nations Waiting For Vaccines
World's biggest vaccine maker Serum Institute of India's Adar Poonawalla this morning urged the nations to "be patient" amid the wait for Covishield, the coronavirus vaccine that the SII has developed in partnership with the Oxford University and British-Swedish pharma firm AstraZeneca.
-
Russian Covid Vaccine Sputnik Could Be Available In India By April: 10 Points
Russian-made Coronavirus vaccine Sputnik -- peer-reviewed by the Lancet Medical Journal -- is undergoing trials in India and could be available for use soon. "I believe the vaccine should be available in India from March- April," Deepak Sapra, the chief of API and pharma services at Dr Reddy's Laboratories, which is manufacturing the vaccine, told...
-
"Hope To Launch Covovax By June 2021": Serum Institute's Adar Poonawalla
Serum Institute of India, the world's biggest vaccine maker, is hopeful of launching Covovax - developed in partnership with American vaccine developer Novavax - by June, its CEO Adar Poonawalla said today. The US-based pharma firm's Covid jab was found to be 89.3 per cent effective in a UK trial.
-
"Happy New Year, All Risks Paid Off": Adar Poonawalla On Vaccine Approval
All the risks taken by Serum Institute have finally paid off, tweeted Adar Poonawalla, the chief executive of the Pune-based vaccine manufacturer, shortly after the country's drug regulator cleared its Covishield vaccine for emergency approval in India.Mr Poonawalla reiteratedthat the Covishieldvaccine -- developed by Serum Institute of India in pa...
-
After Pfizer, Serum Institute Of India Seeks Approval For Covid Vaccine
Serum Institute of India, the world's largest vaccine maker by number of doses produced, has sought government approval for emergency use authorisation of the coronavirus vaccine that it is developing with the University of Oxford and British drugmaker AstraZeneca, sources have said.
-
Applying For Emergency Use Of Covid Vaccine In 2 Weeks: Serum Institute
The Serum Institute will apply within two weeks for an emergency use license of the coronavirus vaccine being developed by the University of Oxford and pharma giant AstraZeneca, the vaccine maker's chief Adar Poonawalla said on Saturday after a meeting with Prime Minister Narendra Modi.
-
PM's 3-City Vaccine Tour Today: Zydus, Bharat Biotech, Serum Institute
Prime Minister Narendra Modi will visit pharma major Zydus Cadila's plant near Ahmedabad on Saturday to get information about the development of its COVID-19 vaccine, Gujarat Deputy Chief Minister Nitin Patel said today.
